27 related articles for article (PubMed ID: 9591782)
1. The Relevant Participation of Prolactin in the Genesis and Progression of Gynecological Cancers.
Ramírez-de-Arellano A; Villegas-Pineda JC; Hernández-Silva CD; Pereira-Suárez AL
Front Endocrinol (Lausanne); 2021; 12():747810. PubMed ID: 34745013
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-7a2 Regulates Prolactin in Developing Lactotrophs and Prolactinoma Cells.
LaPierre MP; Godbersen S; Torres Esteban M; Schad AN; Treier M; Ghoshdastider U; Stoffel M
Endocrinology; 2021 Feb; 162(2):. PubMed ID: 33248443
[TBL] [Abstract][Full Text] [Related]
3. Olfactory marker protein regulates prolactin secretion and production by modulating Ca
Kang CW; Han YE; Lee MK; Cho YH; Kang N; Koo J; Ku CR; Lee EJ
Exp Mol Med; 2018 Apr; 50(4):1-11. PubMed ID: 29622766
[TBL] [Abstract][Full Text] [Related]
4. PI3K/Akt/mTOR pathway involvement in regulating growth hormone secretion in a rat pituitary adenoma cell line.
Di Pasquale C; Gentilin E; Falletta S; Bellio M; Buratto M; Degli Uberti E; Chiara Zatelli M
Endocrine; 2018 May; 60(2):308-316. PubMed ID: 29080043
[TBL] [Abstract][Full Text] [Related]
5. Cell type influences the molecular mechanisms involved in hormonal regulation of ERG K+ channels.
Carretero L; Barros F; Miranda P; Fernández-Trillo J; Machín A; de la Peña P; Domínguez P
Pflugers Arch; 2012 Apr; 463(5):685-702. PubMed ID: 22415214
[TBL] [Abstract][Full Text] [Related]
6. Effects of combination of proliferative agents and erythropoietin on left ventricular remodeling post-myocardial infarction.
Kanashiro-Takeuchi RM; Takeuchi LM; Hatzistergos K; Quevedo H; Selem SM; Treuer AV; Premer C; Balkan W; Margitich I; Song Y; Hu Q; Hare JM
Clin Transl Sci; 2011 Jun; 4(3):168-74. PubMed ID: 21707946
[TBL] [Abstract][Full Text] [Related]
7. Biological significance of prolactin in gynecologic cancers.
Levina VV; Nolen B; Su Y; Godwin AK; Fishman D; Liu J; Mor G; Maxwell LG; Herberman RB; Szczepanski MJ; Szajnik ME; Gorelik E; Lokshin AE
Cancer Res; 2009 Jun; 69(12):5226-33. PubMed ID: 19491263
[TBL] [Abstract][Full Text] [Related]
8. Pituitary Ets-1 and GABP bind to the growth factor regulatory sites of the rat prolactin promoter.
Schweppe RE; Gutierrez-Hartmann A
Nucleic Acids Res; 2001 Mar; 29(5):1251-60. PubMed ID: 11222776
[TBL] [Abstract][Full Text] [Related]
9. Association with Ets-1 causes ligand- and AF2-independent activation of nuclear receptors.
Tolón RM; Castillo AI; Jiménez-Lara AM; Aranda A
Mol Cell Biol; 2000 Dec; 20(23):8793-802. PubMed ID: 11073980
[TBL] [Abstract][Full Text] [Related]
10. Ets transcription factors: nuclear effectors of the Ras-MAP-kinase signaling pathway.
Wasylyk B; Hagman J; Gutierrez-Hartmann A
Trends Biochem Sci; 1998 Jun; 23(6):213-6. PubMed ID: 9644975
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-1 stimulates rat prolactin gene expression by a Ras, ETS and phosphatidylinositol 3-kinase dependent mechanism.
Castillo AI; Tolon RM; Aranda A
Oncogene; 1998 Apr; 16(15):1981-91. PubMed ID: 9591782
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of pituitary-specific gene expression by insulin-like growth factor 1 in rat pituitary GH4C1 and GH3 cells.
Castillo AI; Aranda A
Endocrinology; 1997 Dec; 138(12):5442-51. PubMed ID: 9389530
[TBL] [Abstract][Full Text] [Related]
13. The activity of the Ets transcription factor PEA3 is regulated by two distinct MAPK cascades.
O'Hagan RC; Tozer RG; Symons M; McCormick F; Hassell JA
Oncogene; 1996 Sep; 13(6):1323-33. PubMed ID: 8808707
[TBL] [Abstract][Full Text] [Related]
14. IGF-I and vasoactive intestinal peptide (VIP) regulate cAMP-response element-binding protein (CREB)-dependent transcription via the mitogen-activated protein kinase (MAPK) pathway in pituitary cells: requirement of Rap1.
Fernández M; Sánchez-Franco F; Palacios N; Sánchez I; Cacicedo L
J Mol Endocrinol; 2005 Jun; 34(3):699-712. PubMed ID: 15956341
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
